Original Article
Clinical analysis of cryptococcosis neoformans infection in patients with connective tissue disease
Su Huiying, Jin Yuebo, Wang Naidi, An Yuan
Published 2022-09-15
Cite as Chin J Rheumatol, 2022, 26(9): 577-582. DOI: 10.3760/cma.j.cn141217-20211214-00506
Abstract
ObjectiveTo improve the level of clinical diagnosis and treatment by analyzing the clinical features and relevant factors of cryptococcosis neoformans in patients with connective tissue disease(CTD).
MethodsTwelve patients with CTD and cryptococcosis neoformans infection in Peking University People's Hospital from January 2010 to April 2021 were retrospectively enrolled. Clinical and laboratory data, treatment and outcome were collected and analyzed. Independent sample t-test or Rank-sum test was used.
ResultsThe age of the patients ranged from 18 to 85 years old(mean 51 years old), all of whom were female. None of them were exposed to pigeons and their feces. Of the 12 patients, 3 patients suffered from rheumatoid arthritis, 7 patients had systemic lupus erythematosus, 1 patient was diagnosed with primary Sjögren's syndrome, and 1 patient was diagnosed as undifferentiated connective tissue disease. Four cases were cryptococcal meningitis, 8 were pulmonary cryptococcosis. None of the 12 patients had immunodeficiency virus infection. All 12 patients were given glucocorticoid alone or combined with immunosuppressive or biological agents. All were detected with positive cryptococcus neoformans antigen in serum; 6 got lumbar puncture, 2 cases were positive for ink stain, cerebrospinal fluid (CSF) culture were positive in 2, in whom 3 had high intracranial pressure, in which the highest one was more than 600 mmH2O (1 mmH2O=0.009 8 kPa); 7 cases underwent lung biopsy. Among these patients, all were positive for cryptococcosis neoformans in lung tissue pathological examination; 6 had the number of peripheral lymphocytes less than 1.0×109/L, and 2 were detected for the number of CD4+ T cell, which was significantly decreased. As for the initial anti-fungal drug therapy, all cases were treated with fluconazole intravenously; 2 were treated with combined amphotericin, 1 was treated with combined fluorocytosine, 1 was treated with amphotericin and fluorocytosine. Then oral flu-conazole was prescribed as sequential therapy. The whole treatmentcourse ranged from 4 to 21 months. Eleven patients were cured, and 1 was relieved.
ConclusionPatients with connective tissue disease complicated with cryptococcus neoformans infection have atypical clinical symptoms. Treatment with immunosuppressive drugs and glucocorticoids are related causes. Patients with decreased peripheral blood lymphocytes, especially CD4+ T cell, are more susceptible to infection. Early diagnosis and timely treatment are the key to improve the prognosis and cure of the disease.
Key words:
Connective tissue disease; Pulmonary cryptococcosis; Cryptococcal meningitis
Contributor Information
Su Huiying
Department of Rheumatology and Immunology, PuYang People's Hospital, Henan 457000, China
Jin Yuebo
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China
Wang Naidi
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China
An Yuan
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China